Kingdom funder portal

Capital with eternal purpose.

Investing in frontier science to expand the Kingdom and equip biblical leaders. Vertex Catalyst Group offers a dual-model investment ecosystem — fund a single vetted R&D project and share directly in its intellectual property, or take private equity in the group and participate across the entire portfolio of patents, spin-offs and licensing income. Every allocation is structured to generate multi-generational returns that fund domestic and global Kingdom expansion, resource ministry, and strengthen the resilience of the local church.

Investment Notice — Rule 506(c) · Accredited Investors Only

The investment opportunities described on this page are private offerings made pursuant to Rule 506(c) of Regulation D under the Securities Act of 1933, as amended, and are available exclusively to verified accredited investors as defined under SEC Rule 501(a). These offerings are not registered with the U.S. Securities and Exchange Commission (SEC). Under Rule 506(c), Vertex Catalyst Group LLC may engage in general solicitation and general advertising; however, all investors must independently verify their accredited investor status through documentation satisfactory to the company prior to any participation. No sale of securities will be made to any investor whose accreditation has not been independently verified. Investment in early-stage ventures involves substantial risk, including the potential loss of the entire investment. Nothing on this page constitutes a registered public offering or a solicitation to any person who is not a verified accredited investor. Any formal offer will be made exclusively through definitive offering documents delivered to verified accredited investors. Prospective investors are strongly encouraged to consult independent legal and financial counsel before making any investment decision.

Choose your pathway

Project IP sponsorship or corporate equity.

Both models are structured for long-arc, royalty-bearing returns. Select the exposure that fits your mandate.

Option A

Invest in Research Projects

Direct Project Funding & IP Rights

Direct capital allocation into high-impact, vetted R&D projects across our seven research disciplines — Life Sciences, Information Technology & AI, Physics & Engineering, Sustainability & Energy, Exploration, Facility Usage, and Creation Science.

IP Ownership Model

  • Maximum 50% IP allocation to investors. Fund 100% of a project's target and you secure 50% of the resulting IP rights, licensing revenues and royalties.
  • Pro-rata scaling. Partial funding scales your IP equity proportionally — funding 50% of the capital target grants 25% IP ownership.
  • Fixed institutional retainers. Vertex Catalyst Group always retains 30% of the IP; the Lead Researcher / Research Group retains 20%.

IP & Patent Cost Allocation

  • Initial project investment strictly funds research, lab operations, materials and execution.
  • IP / patent / trademark prosecution and registration costs are separate and evaluated upon project completion.
  • Upon consensus on the commercialization pathway, filing / registration costs are shared 70% by the Project Investor(s) and 30% by Vertex Catalyst Group.
Enter Funder Portal / View Open Projects →
Option B

Invest in Vertex Catalyst Group LLC

Corporate Private Equity & Membership Units

Acquire private equity membership units directly in Vertex Catalyst Group LLC (our sovereign IP holding and commercialization vehicle) — gaining diversified exposure across our entire translational research portfolio rather than being tied to a single project.

Highlights

  • Broad Portfolio Diversification: Direct exposure across our full spectrum of defensible intellectual property, deep-tech hardware platforms (including the Nexus Bio-Bridge), life science formulations, and emerging commercial spin-offs.
  • Predictable Commercialization Pipeline: Systematic intake and acceleration of 10+ high-rigor translational R&D initiatives annually, targeting a minimum of 2+ defensible commercial patents and spin-offs per year.
  • Sovereign Royalty & Licensing Cash Flow: Pro-rata participation in commercial technology licensing agreements, sovereign IP royalty distributions, non-dilutive grant matching, and long-term liquidity events.
  • Capital-Efficient Ecosystem: Headquartered in Greenville, South Carolina, maximizing regional and federal non-dilutive innovation funding to de-risk capital deployment.
Inquire About Private Equity →
Transparency

How the split works.

Every Option A project carries the same fixed governance structure. Fund the full target and you reach the 50% investor ceiling; institutional retainers never change.

IP Ownership (at 100% funding)

Investor share scales pro-rata with the portion of the funding target provided.

Patent / Filing Cost Split (upon commercialization)

Filing / registration costs are evaluated and shared only after a commercialization pathway is agreed.

Governance & assurance: financial administration by JNP Chartered Accountants; IP, corporate and contract governance by MVSK Attorneys. All allocations are formalized under binding agreements and NDA. Figures illustrate the standard framework; program-level terms are confirmed in writing per project.

Data room

Request access to the data room.

Specific funding metrics, capitalization details, and program-level financials are shared privately with qualified parties under NDA. Submit your details and a member of the investment desk will be in touch.

  • Confidential review process
  • Direct introduction to the investment desk
  • Access granted only after qualification

Regulatory Notice: Vertex Catalyst Group LLC offers private membership units exclusively to verified accredited investors pursuant to Rule 506(c) of Regulation D, Securities Act of 1933, as amended. General solicitation is permitted under Rule 506(c); however, accreditation must be independently verified for each investor prior to any sale — self-certification is not sufficient. This page does not constitute a registered public offering. No securities are offered to non-accredited investors under any circumstance. A Form D notice will be filed with the U.S. Securities and Exchange Commission within 15 calendar days of the first sale of securities, as required. Applicable state securities (Blue Sky) notice filings will be made as required by the laws of each applicable jurisdiction. Vertex Catalyst Group LLC strongly recommends that all prospective investors consult qualified independent legal and financial counsel before making any investment commitment.